Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
OPERATING ACTIVITIES
Net (loss) income	$ (23,058,135)	$ 17,377,614
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	30,074	28,801
Stock-based compensation	881,150	3,672,420
Loss from change in fair value of promissory notes	6,743,736	1,304,000
Loss (gain) from change in fair value of warrant liability	2,791,813	(40,272,880)
Loss on equity method investment	38,634	33,295
Changes in operating assets and liabilities:
Accounts receivable	1,376,322
Inventory	(119,660)	(3,109,397)
Prepaid expenses and other current assets	(439,855)	5,633,097
Operating lease liabilities	(13,499)	(12,071)
Accounts payable	(2,873,739)	4,224,022
Accrued expenses	(295,952)	153,764
Net cash used in operating activities	(14,939,111)	(10,967,335)
FINANCING ACTIVITIES
Proceeds from the sale of common stock and warrants to purchase common stock, net of issuance costs	14,931,536	1,742,373
Proceeds from exercise of common stock warrants	601,914
Net cash provided by financing activities	15,533,450	1,742,373
Net increase (decrease) in cash and cash equivalents	594,339	(9,224,962)
Cash and cash equivalents at beginning of year	8,083,085	14,927,538
Cash and cash equivalents at end of period	8,677,424	5,702,576
Supplemental schedule of non-cash financing activities:
Convertible promissory note converted into common stock	30,736
Common stock and warrant issuance costs in accounts payable and accrued expenses	61,230
Reclassification of deferred offering costs against ATM proceeds	$ 54,433	$ 6,331